Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |